Eltrekibart

DB19017InvestigationalProtein Based Therapies

Eltrekibart is under investigation in clinical trial NCT06046729 (A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa).

Mechanism: Pharmacologically active on Platelet basic protein, Interleukin-8, and Growth-regulated alpha protein
Curator reviewed
Code names: LY-3041658

Resolves to

Compound

UNIIWB62WIH13ECAS2484883-56-7

Targets

P02775PPBPP10145CXCL8P09341CXCL1P19875CXCL2P42830CXCL5P19876CXCL3P80162CXCL6

What you can answer from here — as of September 18, 2026

7Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

14+ReferencesStructured and connected to the statements they support

Which drugs share a target with Eltrekibart, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account